ATE349459T1 - Polymorph b eines bekannten thiophencarbonsäuredodecahydrocyclopenta(a)phen ntrenylesters - Google Patents

Polymorph b eines bekannten thiophencarbonsäuredodecahydrocyclopenta(a)phen ntrenylesters

Info

Publication number
ATE349459T1
ATE349459T1 AT03766325T AT03766325T ATE349459T1 AT E349459 T1 ATE349459 T1 AT E349459T1 AT 03766325 T AT03766325 T AT 03766325T AT 03766325 T AT03766325 T AT 03766325T AT E349459 T1 ATE349459 T1 AT E349459T1
Authority
AT
Austria
Prior art keywords
ntrenyl
dodecahydrocyclopenta
polymorpho
phen
ester
Prior art date
Application number
AT03766325T
Other languages
German (de)
English (en)
Inventor
Guido Jordine
Michael Mutz
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE349459T1 publication Critical patent/ATE349459T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03766325T 2002-07-29 2003-07-28 Polymorph b eines bekannten thiophencarbonsäuredodecahydrocyclopenta(a)phen ntrenylesters ATE349459T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0217504.0A GB0217504D0 (en) 2002-07-29 2002-07-29 Organic compounds

Publications (1)

Publication Number Publication Date
ATE349459T1 true ATE349459T1 (de) 2007-01-15

Family

ID=9941275

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03766325T ATE349459T1 (de) 2002-07-29 2003-07-28 Polymorph b eines bekannten thiophencarbonsäuredodecahydrocyclopenta(a)phen ntrenylesters

Country Status (30)

Country Link
US (1) US7683048B2 (https=)
EP (2) EP1554303B1 (https=)
JP (1) JP2006501207A (https=)
KR (1) KR100688371B1 (https=)
CN (1) CN1305892C (https=)
AR (1) AR040692A1 (https=)
AT (1) ATE349459T1 (https=)
AU (1) AU2003251651B2 (https=)
BR (1) BR0313044A (https=)
CA (1) CA2493330C (https=)
CY (1) CY1106406T1 (https=)
DE (1) DE60310747T2 (https=)
DK (1) DK1554303T3 (https=)
EC (1) ECSP055579A (https=)
ES (1) ES2279970T3 (https=)
GB (1) GB0217504D0 (https=)
HK (1) HK1080484B (https=)
IL (2) IL166287A0 (https=)
MX (1) MXPA05001173A (https=)
MY (1) MY136407A (https=)
NO (1) NO20050806L (https=)
NZ (2) NZ537868A (https=)
PE (1) PE20040722A1 (https=)
PL (1) PL209409B1 (https=)
PT (1) PT1554303E (https=)
RU (2) RU2330043C2 (https=)
SI (1) SI1554303T1 (https=)
TW (1) TWI309164B (https=)
WO (1) WO2004013156A1 (https=)
ZA (1) ZA200500370B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
SI1775305T1 (sl) 2000-08-05 2015-01-30 Glaxo Group Limited S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
KR100831534B1 (ko) 2001-04-30 2008-05-22 글락소 그룹 리미티드 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523654D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0603783D0 (en) * 2006-02-24 2006-04-05 Novartis Ag Organic compounds
RU2487131C2 (ru) * 2008-03-14 2013-07-10 Оцука Фармасьютикал Ко., Лтд. Ингибитор ммр-2 и/или ммр-9

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU550939A1 (ru) * 1975-05-19 1994-07-15 Институт химии древесины АН ЛатвССР 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли
JPH08291073A (ja) * 1995-04-22 1996-11-05 Kissei Pharmaceut Co Ltd 医薬品組成物及びその製造方法
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CN1305892C (zh) 2007-03-21
PE20040722A1 (es) 2004-11-29
KR100688371B1 (ko) 2007-03-02
DK1554303T3 (da) 2007-04-30
ES2279970T3 (es) 2007-09-01
PT1554303E (pt) 2007-03-30
TW200401633A (en) 2004-02-01
HK1080484A1 (en) 2006-04-28
DE60310747T2 (de) 2007-10-11
US7683048B2 (en) 2010-03-23
CA2493330A1 (en) 2004-02-12
PL209409B1 (pl) 2011-08-31
WO2004013156A1 (en) 2004-02-12
JP2006501207A (ja) 2006-01-12
ZA200500370B (en) 2006-07-26
US20060166954A1 (en) 2006-07-27
IL184848A0 (en) 2007-12-03
AR040692A1 (es) 2005-04-13
RU2005105688A (ru) 2005-10-10
KR20050033632A (ko) 2005-04-12
GB0217504D0 (en) 2002-09-04
EP1554303A1 (en) 2005-07-20
NZ537868A (en) 2006-11-30
PL373140A1 (en) 2005-08-22
NZ549713A (en) 2008-04-30
RU2330043C2 (ru) 2008-07-27
AU2003251651A1 (en) 2004-02-23
IL166287A0 (en) 2006-01-15
EP1554303B1 (en) 2006-12-27
EP1676854A1 (en) 2006-07-05
HK1080484B (en) 2007-08-03
BR0313044A (pt) 2005-06-14
NO20050806L (no) 2005-02-15
CN1671731A (zh) 2005-09-21
DE60310747D1 (en) 2007-02-08
SI1554303T1 (sl) 2007-06-30
ECSP055579A (es) 2005-04-18
CY1106406T1 (el) 2011-10-12
TWI309164B (en) 2009-05-01
RU2007143025A (ru) 2009-01-20
MY136407A (en) 2008-09-30
MXPA05001173A (es) 2005-05-16
CA2493330C (en) 2011-08-23
RU2348646C1 (ru) 2009-03-10
AU2003251651B2 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
PL378181A1 (pl) Pochodne kwasu hydroksamidowego jako inhibitory deacetylazy histonowej (HDAC)
NO20052019D0 (no) Blanding for a inhibere sekresjon av magesyre
DK1488790T3 (da) Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat
DK2275401T3 (da) Krystallin 1{[(alpha-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexan-eddikesyre
IS7574A (is) Fenýlalkanósýra og fenýloxýalkanósýru afleiður sem HPPAR virkjar
FR2898356B1 (fr) Diesters d'acides carboxylique ramifies
ATE517887T1 (de) Neue 2-pyridincarbonsäureamidderivate
HUP0401233A3 (en) Aromatic hydroxamic acid derivatives useful as hdac inhibitors
EP1515601A4 (en) NUCLEIC ACID SEQUENCES AND USE METHOD FOR THE PRODUCTION OF PLANTS WITH MODIFIED MULTIPLE UNSATURATED FATTY ACIDS
PL377696A1 (pl) Enancjomery pochodnych kwasu tiofenohydroksamowego i ich zastosowanie jako inhibitorów HDAC
DE50212761D1 (de) Neuartige aminodicarbonsäurederivate
ATE410407T1 (de) Zimtsäureamidderivate
NO20055370D0 (no) Alfa-substituert karboksylsyre som PPAR modulatorer
ATE349459T1 (de) Polymorph b eines bekannten thiophencarbonsäuredodecahydrocyclopenta(a)phen ntrenylesters
EE200300343A (et) Pantoteenhappe võimendatud produktsiooni meetod
IS8231A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
AU2003299095A1 (en) Synthesis of thiophenecarboxylic acid esters for the production of ranelic acid salts
IS7446A (is) Aðferð til að mynda næriþekjur prímata
NO20043569L (no) Metabolitter av(3-{[4-tert-butyl-benzyl)-(pyridin-3-sulfonyl)-amino]-metyl}-fenoksy)-eddiksyre
AP2076A (en) New Heterocyclic carboxylic acid amide derivatives
AP2005003329A0 (en) Chemically acidified formula
PL378119A1 (pl) Kwasy karboksylowe
FI20020593A0 (fi) Menetelmä konjugoidun linolihapon valmistamiseksi
EP1874755A4 (en) BENZOTHIOPHENE-hydroxamic acid derivatives
AU2003221495A1 (en) Production of carboxylic acid amides

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1554303

Country of ref document: EP